Li Limei, Liu Xiaodong, Liu Tingting, Liu Yue, Zhang Zhili
The First Hospital of Qinhuangdao, Qinhuangdao, China.
Eur Spine J. 2025 Jun 14. doi: 10.1007/s00586-025-08996-6.
Cervical chest pain (CCP) is an atypical symptom of cervical spine disease that often overlaps with other chest-related diseases but a type of noncardiogenic chest pain. The obvious relief of CCP after selective cervical nerve root block (SCNRB) near intervertebral disc herniation under ultrasound guidance should be considered to help identify the potential pathological source.The purpose of this study was to explore the application value of a positive ultrasound-guided SCNRB test before percutaneous cervical nucleoplasty (PCN) in the treatment of patients with CCP.
A retrospective analysis of 66 patients with CCP who underwent PCN was conducted. Patients were divided into a control group (PN group, n = 32) and an ultrasound-guided group (UPN group, n = 34) according to the absence or presence of ultrasound-guided SCNRB before surgery. The visual analogue scale (VAS) score, neck disability index (NDI), Pittsburgh Sleep Quality Index (PSQI), and proportion of patients taking oral analgesics before and at 1 week, 1 month, 3 months, and 6 months after surgery were recorded. The clinical effect according to the Odom criteria was recorded 6 months after surgery. The occurrence of adverse events was recorded to evaluate safety.
Compared with baseline, both groups showed significant improvement in VAS score, NDI, and PSQI at 1 week, 1 month, 3 months, and 6 months after surgery (P < 0.05). The proportion of patients taking oral analgesics sharply decreased at each time point after surgery. The VAS score, NDI, and PSQI at 1 week, 1 month, 3 months, and 6 months after surgery in the UPN group were lower than those in the PN group, and the Odom criteria rate of excellent and good performance in the UPN group was 91.2%, which was significantly greater than that in the PN group at 75.0% (P < 0.05).
PCN can effectively alleviate the severity of chest pain, and improve sleep quality in patients with CCP. A positive ultrasound-guided SCNRB test before PCN can play a guiding role in identifying diseased nerves to improve the clinical efficacy of PCN in the treatment of CCP and can serve as a clinical reference.
颈源性胸痛(CCP)是颈椎病的一种非典型症状,常与其他胸部相关疾病重叠,属于非心源性胸痛。在超声引导下,靠近椎间盘突出处进行选择性颈神经根阻滞(SCNRB)后CCP明显缓解,应考虑有助于识别潜在的病理来源。本研究的目的是探讨在经皮颈椎间盘成形术(PCN)治疗CCP患者前,超声引导下SCNRB试验阳性的应用价值。
对66例行PCN的CCP患者进行回顾性分析。根据术前是否进行超声引导下SCNRB,将患者分为对照组(PN组,n = 32)和超声引导组(UPN组,n = 34)。记录术前及术后1周、1个月、3个月和6个月的视觉模拟评分(VAS)、颈部功能障碍指数(NDI)、匹兹堡睡眠质量指数(PSQI)以及服用口服镇痛药的患者比例。术后6个月根据奥多姆标准记录临床疗效。记录不良事件的发生情况以评估安全性。
与基线相比,两组术后1周、1个月、3个月和6个月的VAS评分、NDI和PSQI均有显著改善(P < 0.05)。术后各时间点服用口服镇痛药的患者比例急剧下降。UPN组术后1周、1个月、3个月和6个月的VAS评分、NDI和PSQI均低于PN组,UPN组的奥多姆标准优良率为91.2%,显著高于PN组的75.0%(P < 0.05)。
PCN可有效减轻CCP患者胸痛的严重程度,改善睡眠质量。PCN前超声引导下SCNRB试验阳性对识别病变神经具有指导作用,可提高PCN治疗CCP的临床疗效,可供临床参考。